| 17alpha-ethynylestradiol | increases expression | ISO | RGD:732617 | 6480464 | Ethinyl Estradiol results in increased expression of ATP5C1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of ATP5C1 mRNA | CTD | PMID:15212814 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5C1 mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:732616 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATP5C1 mRNA | CTD | PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732617 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ATP5C1 promoter] | CTD | PMID:19654925 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATP5C1 mRNA | CTD | PMID:16483693 |
| clofibrate | multiple interactions | ISO | RGD:732617 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5C1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of ATP5C1 protein | CTD | PMID:16470657 |
| clofibrate | increases expression | ISO | RGD:732617 | 6480464 | Clofibrate results in increased expression of ATP5C1 mRNA | CTD | PMID:17585979 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ATP5C1 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ATP5C1 mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732616 | 6480464 | Copper Sulfate results in decreased expression of ATP5C1 mRNA | CTD | PMID:20599845 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732616 | 6480464 | Copper Sulfate results in decreased expression of ATP5C1 mRNA | CTD | PMID:19549813 PMID:20599845 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732616 | 6480464 | Copper Sulfate results in decreased expression of ATP5C1 mRNA | CTD | PMID:20599845 PMID:19549813 |
| copper(2+) sulfate | increases expression | ISO | RGD:732616 | 6480464 | Copper Sulfate results in increased expression of ATP5C1 mRNA | CTD | PMID:20599845 |
| cyclosporin A | decreases expression | ISO | RGD:732616 | 6480464 | Cyclosporine results in decreased expression of ATP5C1 mRNA | CTD | PMID:20106945 |
| diarsenic trioxide | increases expression | ISO | RGD:732616 | 6480464 | arsenic trioxide results in increased expression of ATP5C1 mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | decreases expression | ISO | RGD:732617 | 6480464 | Dibutyl Phthalate results in decreased expression of ATP5C1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:732617 | 6480464 | Dibutyl Phthalate results in decreased expression of ATP5C1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ATP5C1 mRNA | CTD | PMID:21266533 |
| flutamide | increases expression | ISO | RGD:732617 | 6480464 | Flutamide analog results in increased expression of ATP5C1 mRNA; more ... | CTD | PMID:17702527 |
| isotretinoin | decreases expression | ISO | RGD:732616 | 6480464 | Isotretinoin results in decreased expression of ATP5C1 mRNA | CTD | PMID:20436886 |
| lamivudine | multiple interactions | ISO | RGD:732617 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5C1 mRNA | CTD | PMID:18313992 |
| manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of ATP5C1 mRNA | CTD | PMID:22281203 |
| paracetamol | multiple interactions | ISO | RGD:732617 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ATP5C1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:732617 | 6480464 | Acetaminophen results in decreased expression of ATP5C1 mRNA | CTD | PMID:15030884 |
| paracetamol | affects expression | ISO | RGD:732617 | 6480464 | Acetaminophen affects the expression of ATP5C1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ATP5C1 protein | CTD | PMID:16538041 |
| phlorizin | increases expression | ISO | RGD:732617 | 6480464 | Phlorhizin results in increased expression of ATP5C1 mRNA | CTD | PMID:22538082 |
| rosiglitazone | affects expression | ISO | RGD:732617 | 6480464 | rosiglitazone affects the expression of ATP5C1 mRNA | CTD | PMID:22013433 |
| rotenone | increases expression | ISO | RGD:732617 | 6480464 | Rotenone results in increased expression of ATP5C1 mRNA | CTD | PMID:17702527 |
| silicon dioxide | decreases expression | ISO | RGD:732617 | 6480464 | Silicon Dioxide results in decreased expression of ATP5C1 mRNA | CTD | PMID:19073995 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of ATP5C1 mRNA | CTD | PMID:21827849 |
| zidovudine | multiple interactions | ISO | RGD:732617 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of ATP5C1 mRNA | CTD | PMID:18313992 |